guidelines:
  1: Fong_Clinical_Risk_Score_for_Colorectal_Cancer_Recurrence.v1
test_cases:
- id: Score 0
  input:
    1:
      gt0003|Disease-free interval <12 months: 0|local::at0008|No|
      gt0004|>1 tumor: 0|local::at0011|No|
      gt0005|Preoperative CEA level >200 ng/mL: 0|local::at0014|No|
      gt0006|Node-positive primary: 0|local::at0005|No|
      gt0007|Size of largest tumor >5cm: 0|local::at0017|No|
  expected_output:
    1:
      gt0011|Total Points: 0
      gt0024|Survival Percentage: 0|local::at0003|93% 1-year survival after metastasectomy|

- id: Score 1
  input:
    1:
      gt0003|Disease-free interval <12 months: 1|local::at0010|Yes|
      gt0004|>1 tumor: 0|local::at0011|No|
      gt0005|Preoperative CEA level >200 ng/mL: 0|local::at0014|No|
      gt0006|Node-positive primary: 0|local::at0005|No|
      gt0007|Size of largest tumor >5cm: 0|local::at0017|No|
  expected_output:
    1:
      gt0011|Total Points: 1
      gt0024|Survival Percentage: 1|local::at0004|91% 1-year survival after metastasectomy|

- id: Score 2
  input:
    1:
      gt0003|Disease-free interval <12 months: 1|local::at0010|Yes|
      gt0004|>1 tumor: 1|local::at0013|Yes|
      gt0005|Preoperative CEA level >200 ng/mL: 0|local::at0014|No|
      gt0006|Node-positive primary: 0|local::at0005|No|
      gt0007|Size of largest tumor >5cm: 0|local::at0017|No|
  expected_output:
    1:
      gt0011|Total Points: 2
      gt0024|Survival Percentage: 2|local::at0005|89% 1-year survival after metastasectomy|

- id: Score 3
  input:
    1:
      gt0003|Disease-free interval <12 months: 1|local::at0010|Yes|
      gt0004|>1 tumor: 1|local::at0013|Yes|
      gt0005|Preoperative CEA level >200 ng/mL: 1|local::at0015|Yes|
      gt0006|Node-positive primary: 0|local::at0005|No|
      gt0007|Size of largest tumor >5cm: 0|local::at0017|No|
  expected_output:
    1:
      gt0011|Total Points: 3
      gt0024|Survival Percentage: 3|local::at0006|86% 1-year survival after metastasectomy|

- id: Score 4
  input:
    1:
      gt0003|Disease-free interval <12 months: 1|local::at0010|Yes|
      gt0004|>1 tumor: 1|local::at0013|Yes|
      gt0005|Preoperative CEA level >200 ng/mL: 1|local::at0015|Yes|
      gt0006|Node-positive primary: 1|local::at0006|Yes|
      gt0007|Size of largest tumor >5cm: 0|local::at0017|No|
  expected_output:
    1:
      gt0011|Total Points: 4
      gt0024|Survival Percentage: 4|local::at0007|70% 1-year survival after metastasectomy|

- id: Score 5
  input:
    1:
      gt0003|Disease-free interval <12 months: 1|local::at0010|Yes|
      gt0004|>1 tumor: 1|local::at0013|Yes|
      gt0005|Preoperative CEA level >200 ng/mL: 1|local::at0015|Yes|
      gt0006|Node-positive primary: 1|local::at0006|Yes|
      gt0007|Size of largest tumor >5cm: 1|local::at0018|Yes|
  expected_output:
    1:
      gt0011|Total Points: 5
      gt0024|Survival Percentage: 5|local::at0008|71% 1-year survival after metastasectomy|

